SE7813277L - COMPOSITION AND METHODS FOR THE TREATMENT OF HYPERTENSION - Google Patents

COMPOSITION AND METHODS FOR THE TREATMENT OF HYPERTENSION

Info

Publication number
SE7813277L
SE7813277L SE7813277A SE7813277A SE7813277L SE 7813277 L SE7813277 L SE 7813277L SE 7813277 A SE7813277 A SE 7813277A SE 7813277 A SE7813277 A SE 7813277A SE 7813277 L SE7813277 L SE 7813277L
Authority
SE
Sweden
Prior art keywords
hypertension
treatment
composition
methods
Prior art date
Application number
SE7813277A
Other languages
Swedish (sv)
Other versions
SE445173B (en
Inventor
Z P Horovitz
B Rubin
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25343256&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE7813277(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of SE7813277L publication Critical patent/SE7813277L/en
Publication of SE445173B publication Critical patent/SE445173B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE7813277A 1977-12-27 1978-12-22 ORAL, ANTIHYPERTENSIVE COMPOSITION CONTAINING (D-3-MERCAPTO-2-METHYLPROPANOYL) -L-PROLINE AND CERTAIN DIURETIC SE445173B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US86442877A 1977-12-27 1977-12-27

Publications (2)

Publication Number Publication Date
SE7813277L true SE7813277L (en) 1979-06-28
SE445173B SE445173B (en) 1986-06-09

Family

ID=25343256

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7813277A SE445173B (en) 1977-12-27 1978-12-22 ORAL, ANTIHYPERTENSIVE COMPOSITION CONTAINING (D-3-MERCAPTO-2-METHYLPROPANOYL) -L-PROLINE AND CERTAIN DIURETIC

Country Status (30)

Country Link
JP (1) JPS54110333A (en)
AR (1) AR230378A1 (en)
AU (1) AU526239B2 (en)
BE (1) BE873092A (en)
CA (1) CA1120400A (en)
CH (1) CH642542A5 (en)
DE (1) DE2854316C3 (en)
DK (1) DK578778A (en)
EG (1) EG14178A (en)
FI (1) FI783991A (en)
FR (1) FR2413089A1 (en)
GB (1) GB2010675B (en)
GR (1) GR72951B (en)
HK (1) HK45483A (en)
HU (1) HU178747B (en)
IE (1) IE48306B1 (en)
IL (1) IL56281A (en)
IT (1) IT1202811B (en)
KE (1) KE3235A (en)
LU (1) LU80709A1 (en)
MY (2) MY8300240A (en)
NL (2) NL192870C (en)
NO (1) NO784357L (en)
NZ (1) NZ189159A (en)
PH (1) PH22111A (en)
PL (1) PL212188A1 (en)
PT (1) PT68983A (en)
SE (1) SE445173B (en)
SG (1) SG41482G (en)
ZA (1) ZA786948B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5829950B2 (en) * 1978-10-05 1983-06-25 ウェルファイド株式会社 Cyclic iminocarboxylic acid derivatives and their salts
US4350704A (en) 1980-10-06 1982-09-21 Warner-Lambert Company Substituted acyl derivatives of octahydro-1H-indole-2-carboxylic acids
US4482725A (en) * 1980-04-03 1984-11-13 E. R. Squibb & Sons, Inc. S-Acylation products of mercaptoacyl amino acids and carboxyl group containing diuretics
US4344949A (en) 1980-10-03 1982-08-17 Warner-Lambert Company Substituted acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids
US4532342A (en) * 1981-02-20 1985-07-30 Warner-Lambert Company N-substituted amino acids as intermediates in the preparation of acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids
US4552889A (en) * 1983-06-09 1985-11-12 Eli Lilly And Company 3-Mercaptomethyl-2-oxo-1-pyrrolidine acetic acids and use for hypertension
US4898729A (en) * 1983-12-09 1990-02-06 Euroceltique, S.A. Treatment of hypertension, compounds and compositions for antihypertension and diuresis
DE3532036A1 (en) * 1985-09-09 1987-03-26 Hoechst Ag PHARMACEUTICAL PREPARATION FOR TREATING HIGH PRESSURE
DK9200258U4 (en) * 1992-03-11 1993-07-23 Merck & Co Inc Pharmaceutical preparation containing enalapril for use in hypertension
WO1996024358A1 (en) * 1995-02-10 1996-08-15 G.D. Searle & Co. Use of low dose amount of spironolactone for treatment of cardiovascular disease

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU509899B2 (en) * 1976-02-13 1980-05-29 E.R. Squibb & Sons, Inc. Proline derivatives and related compounds

Also Published As

Publication number Publication date
PH22111A (en) 1988-06-01
DE2854316C3 (en) 1994-12-22
CH642542A5 (en) 1984-04-30
NO784357L (en) 1979-06-28
AU4204178A (en) 1979-07-05
IT7831266A0 (en) 1978-12-22
AU526239B2 (en) 1982-12-23
ZA786948B (en) 1980-04-30
DE2854316C2 (en) 1989-08-10
PL212188A1 (en) 1980-02-11
JPS54110333A (en) 1979-08-29
SE445173B (en) 1986-06-09
IE48306B1 (en) 1984-12-12
CA1120400A (en) 1982-03-23
FR2413089B1 (en) 1980-12-26
FI783991A (en) 1979-06-28
NL192870B (en) 1997-12-01
HK45483A (en) 1983-10-28
NL192870C (en) 1998-04-02
AR230378A1 (en) 1984-04-30
DE2854316A1 (en) 1979-07-05
GB2010675B (en) 1982-06-16
SG41482G (en) 1985-01-11
BE873092A (en) 1979-06-27
IT1202811B (en) 1989-02-09
IL56281A0 (en) 1979-03-12
KE3235A (en) 1982-11-05
NL7812164A (en) 1979-06-29
IE782413L (en) 1979-06-27
NL980017I1 (en) 1998-07-01
PT68983A (en) 1979-01-01
EG14178A (en) 1984-06-30
IL56281A (en) 1983-05-15
JPS647045B2 (en) 1989-02-07
LU80709A1 (en) 1979-04-13
FR2413089A1 (en) 1979-07-27
NZ189159A (en) 1984-12-14
HU178747B (en) 1982-06-28
MY8300240A (en) 1983-12-31
DK578778A (en) 1979-06-28
GR72951B (en) 1984-01-17
GB2010675A (en) 1979-07-04
MY102991A (en) 1993-03-31

Similar Documents

Publication Publication Date Title
SE7802899L (en) COMPOSITION AND METHODS FOR TREATING KERATINE MATERIALS WITH CATHONIC AND ANJONIC POLYMERS
SE7803719L (en) KIT AND DEVICE FOR MANUFACTURE OF THE EXPLOSION
SE7809324L (en) TREATMENT OF CARBONABLE MATERIAL
FI780378A (en) ANORDING FOR THE PURPOSE OF THE GRILL- AND THE KAMINELD OR THE LIKNANDE
SE7809005L (en) CONTACT DEVICE AND METHOD OF MANUFACTURE OF THE SAME
FI54842B (en) FORMULATION OF THE IMMUNITATION FOR IMMUNITATION AND ENZYMATION
SE7812339L (en) KIT AND DEVICE FOR THE MANUFACTURE OF METHANE - GAS
FI781521A (en) ADJUSTMENT OF EFFECTIVE EFFECTIVENESS IN THE FOLLOWING MEASURES
SE7801154L (en) COMPOSITIONS FOR THE PREVENTION OF CORROSION AND METHODS OF PREPARING THE SAME
SE7905500L (en) KITS AND DEVICES FOR THE MANUFACTURE OF HERDPLASTIC FOREMALS
SE7809318L (en) KIT AND DEVICE FOR EXHAUST-DEPENDENT REGULATION OF TENDING TIMES
SE7802754L (en) KIT AND DEVICE FOR EXHAUST TREATMENT
SE7806336L (en) KIT AND DEVICE FOR DRINKING OUT OF MINUTES
SE7804962L (en) DITRANOL COMPOSITION FOR THE TREATMENT OF PSORIASIS
SE405012B (en) SET FOR DESIGNATION OF THE POLYETEN
SE7813277L (en) COMPOSITION AND METHODS FOR THE TREATMENT OF HYPERTENSION
SE7807428L (en) PROCEDURE FOR TREATMENT OF VERMEKENSLIGA MATERIAL
SE7804596L (en) PROCEDURE FOR THE PREPARATION OF URBAN DIVIDE
SE7810829L (en) BINDING AND PROCEDURES FOR THE MANUFACTURE OF IT
SE7809687L (en) PROCEDURE FOR DETERMINATION OF CANCEROGENA SUBSTANCES
NO782574L (en) PROCEDURES FOR THE TREATMENT OF TOBACCO
SE7713501L (en) KIT FOR TREATMENT OF ANGA
SE7802024L (en) PROCEDURE FOR THE PREPARATION OF PYRROLOKINOXALINONES AND PYRROLOBENZODIAZEPINONS
SE7806672L (en) PROCEDURE AND DEVICE FOR THE MANUFACTURE OF TILES
FI782169A (en) PROCEDURE FOR THE CONSTRUCTION OF THE INDUSTRY OF THE INDUSTRY AND OF THE INDUSTRY

Legal Events

Date Code Title Description
SPCF Application for supplementary protection certificate filed

Free format text: 7813277

NAL Patent in force

Ref document number: 7813277-6

Format of ref document f/p: F

SPCG Supplementary protection certificate granted

Free format text: 9490190, 940617, EXPIRES: 20031222

NUG Patent has lapsed

Ref document number: 7813277-6

Format of ref document f/p: F